CN208541471U - A kind of compound infusion application - Google Patents
A kind of compound infusion application Download PDFInfo
- Publication number
- CN208541471U CN208541471U CN201721442757.1U CN201721442757U CN208541471U CN 208541471 U CN208541471 U CN 208541471U CN 201721442757 U CN201721442757 U CN 201721442757U CN 208541471 U CN208541471 U CN 208541471U
- Authority
- CN
- China
- Prior art keywords
- layer
- adherent layer
- cold compress
- compound infusion
- back sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
The utility model provides one kind compound infusion application, which is provided simultaneously with advantage of magnesium sulfate dressing and hydrogel cold compress, and has preferable adhesive force, not easily to fall off, sticks comfortably, has both pinprick sterilizing function, use simple and effective.A kind of compound infusion application, including the first adherent layer and the back sheet connecting with the first adherent layer, the other side of back sheet is stained with cold compress patch and disinfection tablet, and there are spacing between cold compress patch and disinfection tablet；First adherent layer is polyethylene film, the back sheet is medical proof fabric, the cold compress patch includes the second adherent layer, hydrogel layer and the nonwoven layer from top to bottom set gradually, second adherent layer is adjacent with back sheet, second adherent layer is polyethylene film, and hydrogel layer is the hydrogel matrix containing magnesium sulfate.The utility model patch is difficult to fall off on the skin, conveniently opens, takes noresidue off；Pinprick sterilizing function is had both, simple and effective is used；Adjuvant treatment effect is good.
Description
Technical field
The utility model relates to a kind of compound infusions to apply, and belong to medical instrument, daily-use chemical industry technical field.
Background technique
For many years, affected part is spread on hydrogel or the gauze that Adlerika impregnates is spread on into affected part, in muscle
Inflammation and swelling caused by subcutaneous sepage swelling, pain and phlebitis, soft tissue inflammation swelling, puncture caused by injection, infusion
Adjuvant treatment.It is used by numerous doctors always, currently used hydrogel plays in adjuvant treatment organizes week to affected part
The cold compress effect of cooling is enclosed, but the effect assisted in the treatment of does not have magnesium sulfate dressing good.Magnesium sulfate dressing needs Extemporaneous, operation
Inconvenience wastes time, and gauze is easy to fall off in use process, and moisture easily evaporates, and has seriously affected the effect of magnesium sulfate dressing.Together
When medical worker need to carry out disinfection to pinprick and syringe needle is fixed when being infused to patient, need to dismantle respectively
It is operated after packaging bag, it is inconvenient for operation, it wastes time.
Utility model content
The purpose of this utility model is to provide a kind of compound infusion applications to solve the problems, such as to propose in background above technology,
The compound infusion application is provided simultaneously with the advantage of magnesium sulfate dressing and hydrogel cold compress, and has preferable adhesive force, is not easy
It falls off, sticks comfortably, have both pinprick sterilizing function, use simple and effective.
The technical scheme adopted by the utility model to solve the technical problem is as follows:
A kind of compound infusion application, including the first adherent layer and the back sheet being connect with the first adherent layer, the first adherent layer
Cold compress patch and disinfection tablet are stained between back sheet, there are spacing between cold compress patch and disinfection tablet；First adherent layer
For polyethylene film, the back sheet is medical proof fabric, the cold compress patch include from top to bottom set gradually it is second anti-sticking
Layer, hydrogel layer and nonwoven layer, the second adherent layer is adjacent with the first adherent layer, and the second adherent layer is polyethylene film, hydrogel
Layer is the hydrogel matrix containing magnesium sulfate, and hydrogel layer is coated between the second adherent layer and nonwoven layer.
Preferably, the back sheet with the quadrangle of the first adherent layer joint face be equipped with triangle or sector it is anti-sticking
Piece.The effect of residual plate is to make the quadrangle of compound infusion application not with user of service's skin adhesive, and personnel convenient to use are using
Compound infusion application is torn off into skin afterwards.
Preferably, the back sheet side is equipped with fixed adhesive plaster.It is defeated when the effect of fixed adhesive plaster is fixed infusion
The position of liquid needle tubing, makes that operator's is easy to operate, saves the time.
Preferably, first adherent layer is the anti-sticking polyethylene film of high density.Density polyethylene film with high abbreviation HDPE
Film has good antiseptic property, electrical property, humidity resistance, leakage performance, and tensile strength is high, and environment-protecting and non-poisonous, comparison is common
Polyethylene film especially has the advantages that antiseepage coefficient is high, particularly suitable as adherent layer.
Preferably, the spacing of the disinfection tablet and cold compress patch is 20-100mm.
Preferably, the disinfection tablet is the crystalline flake of iodine.
The beneficial effects of the utility model are:
The compound infusion of the utility model applies, and smooth surface, sense of touch is excellent, and has excellent peel strength
And hold viscosity energy, patch are difficult to fall off on the skin, conveniently open, take noresidue off；Pinprick sterilizing function is had both, using easy to be high
Effect；Its hydrogel layer combines traditional hydrogel cold compress and magnesium sulfate cold compress, and adjuvant treatment effect is good, without any side effects,
It is easy to use, it is subcutaneous sepage swelling, pain and phlebitis caused by effective prevention and adjuvant treatment intramuscular injection, infusion, soft
Inflammation caused by tissue inflammation swelling, puncture and swelling.
Detailed description of the invention
Fig. 1 is the schematic view of the front view of the utility model；
Fig. 2 is structural schematic diagram at Section A-A in Fig. 1；
Fig. 3 is another structural schematic diagram in Fig. 1 at Section A-A.
In figure: 1, first adherent layer, 2, back sheet, 3, cold compress patch, 4, disinfection tablet, the 5, second adherent layer, 6, hydrogel layer,
7, nonwoven layer, 8, residual plate, 9, fixed adhesive plaster.
Specific embodiment
Below by specific embodiment, and in conjunction with attached drawing, the technical solution of the utility model is made further specifically
It is bright.It should be appreciated that the implementation of the utility model is not limited by the following examples, any form that the utility model is done
On accommodation and/or change fall within scope of protection of the utility model.
Embodiment 1:
The compound infusion application of one kind as depicted in figs. 1 and 2, connect including the first adherent layer 1 and with the first adherent layer
Back sheet 2 is stained with cold compress patch 3 and disinfection tablet 4 between first adherent layer and back sheet, between cold compress patch and disinfection tablet there are
Away from the spacing 30mm of disinfection tablet and cold compress patch, disinfection tablet is the crystalline flake of iodine.
First adherent layer is the anti-sticking polyethylene film of high density, and density polyethylene film with high abbreviation HDPE film has anti-well
Rotten performance, electrical property, humidity resistance, leakage performance, tensile strength is high, environment-protecting and non-poisonous, compares common polythene film, especially has
Have the advantages that antiseepage coefficient is high, particularly suitable as adherent layer.Back sheet side is equipped with fixed adhesive plaster 9, the effect of fixed adhesive plaster
The position of Transfusion needle pipe when being fixed infusion, makes that operator's is easy to operate, saves the time.
Back sheet is medical proof fabric, and cold compress patch includes the second adherent layer 5 from top to bottom set gradually, 6 and of hydrogel layer
Nonwoven layer 7, the second adherent layer is adjacent with back sheet, and the second adherent layer is polyethylene film, and hydrogel layer is to contain magnesium sulfate
Hydrogel matrix, hydrogel layer are coated between the second adherent layer and nonwoven layer.
In use, the position for adjusting compound infusion application first tears the position of the corresponding infusion pinprick of disinfection tablet off first
Medical proof fabric as back sheet is gradually pasted on patient skin with fixed immobilization with adhesive tape Transfusion needle pipe, is made to disappear by adherent layer
Malicious piece covers patient fluid infusion's pinprick, while tearing the second adherent layer off, is fixed on cold compress patch on patient skin, thus makes entirely multiple
Close the position that infusion application is pasted onto patient's needs.
Embodiment 2:
Technical solution with embodiment 1, the difference is that: as shown in figure 3, back sheet with the first adherent layer joint face
Quadrangle be equipped with triangle residual plate 8.The effect of residual plate be make it is compound infusion application quadrangle not with user of service's skin
Compound infusion application is torn off skin after use by bonding, personnel convenient to use.Residual plate can be polyethylene film, can also be with
It is release paper.
Embodiment described above is a kind of preferable scheme of the utility model, is not made to the utility model any
Formal limitation, there are also other variations and modifications on the premise of not exceeding the technical scheme recorded in the claims.
Claims (10)
1. a kind of compound infusion application, it is characterised in that: the compound infusion apply including the first adherent layer (1) and with it is first anti-sticking
The back sheet (2) of layer connection, is stained with cold compress patch (3) and disinfection tablet (4) between the first adherent layer and back sheet, cold compress patch with disappear
There are spacing between malicious piece；First adherent layer is polyethylene film, and the back sheet is medical proof fabric, the cold compress
Patch includes the second adherent layer (5), hydrogel layer (6) and the nonwoven layer (7) that from top to bottom set gradually, the second adherent layer and the
One adherent layer is adjacent, and the second adherent layer is polyethylene film, and hydrogel layer is the hydrogel matrix containing magnesium sulfate, and hydrogel layer applies
It is overlying between the second adherent layer and nonwoven layer.
2. the compound infusion application of one kind according to claim 1, it is characterised in that: the back sheet with it is first anti-sticking
The quadrangle of layer joint face is equipped with the residual plate (8) of triangle or sector.
3. the compound infusion application of one kind according to claim 1 or 2, it is characterised in that: table on first adherent layer
Face is equipped with fixed adhesive plaster (9).
4. the compound infusion application of one kind according to claim 1 or 2, it is characterised in that: first adherent layer is height
The anti-sticking polyethylene film of density.
5. the compound infusion application of one kind according to claim 3, it is characterised in that: first adherent layer is high density
Anti-sticking polyethylene film.
6. the compound infusion application of one kind according to claim 1 or 2, it is characterised in that: the disinfection tablet and cold compress patch
Spacing be 20-100mm.
7. the compound infusion application of one kind according to claim 3, it is characterised in that: between the disinfection tablet and cold compress patch
Away from for 20-100mm.
8. the compound infusion application of one kind according to claim 4, it is characterised in that: between the disinfection tablet and cold compress patch
Away from for 20-100mm.
9. the compound infusion application of one kind according to claim 5, it is characterised in that: between the disinfection tablet and cold compress patch
Away from for 20-100mm.
10. the compound infusion application of one kind according to claim 1, it is characterised in that: the disinfection tablet is the crystalline flake of iodine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721442757.1U CN208541471U (en) | 2017-11-01 | 2017-11-01 | A kind of compound infusion application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201721442757.1U CN208541471U (en) | 2017-11-01 | 2017-11-01 | A kind of compound infusion application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN208541471U true CN208541471U (en) | 2019-02-26 |
Family
ID=65416038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201721442757.1U Active CN208541471U (en) | 2017-11-01 | 2017-11-01 | A kind of compound infusion application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN208541471U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2607900A (en) * | 2021-06-14 | 2022-12-21 | matthews Patrick | Lymphatic-drainage dressing |
-
2017
- 2017-11-01 CN CN201721442757.1U patent/CN208541471U/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2607900A (en) * | 2021-06-14 | 2022-12-21 | matthews Patrick | Lymphatic-drainage dressing |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008033401A3 (en) | Injection and hemostasis site | |
| CN211460793U (en) | Medicinal phlebitis damp-heat application plaster | |
| CN208541471U (en) | A kind of compound infusion application | |
| CN206381207U (en) | A kind of medical application | |
| CN202637674U (en) | Retention needle/retention tube functional fixer | |
| CN103505795B (en) | Combined type functional fixing device (paste/piece/film) for indwelling needle or indwelling tube | |
| CN202637675U (en) | Integral indwelling needle/indwelling tube functional patch | |
| CN206443821U (en) | Medical cold is applied | |
| CN210813121U (en) | Improved vein indwelling plaster | |
| CN209751381U (en) | Foam dressing for preventing phlebitis | |
| CN202637278U (en) | Easily uncovered functional dressing film | |
| WO2009084611A1 (en) | Antipruritic sheet | |
| CN202637673U (en) | Functional fixer for combined indwelling needle/indwelling tube | |
| CN107822685B (en) | Hemostatic cotton patch | |
| CN205460191U (en) | Medical ventilative applying ointment or plaster | |
| CN104707210A (en) | Functionality pasting film used for fixing indwelling needle or indwelling tube | |
| CN214415035U (en) | Waterproof application | |
| CN220424071U (en) | Prevent remaining needle of crush injury and apply ointment or plaster | |
| US12109318B1 (en) | Topical drug delivery devices and methods of use | |
| CN219439712U (en) | External application fixing device used during intravenous infusion medicine extravasation | |
| CN103505796A (en) | Functional fixer (paster/sheet/membrane) of indwelling needle/indwelling tube | |
| CN205235077U (en) | Wet ability is applied ointment or plaster | |
| CN211750447U (en) | Medical adhesive plaster for drawing skin and straightening blood vessels | |
| CN209422218U (en) | Medical cold application | |
| CN203290960U (en) | Nursing patch |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |